Search
for
Sort by
Research 241–270 of 1000+
- Artificial Intelligence in Hair Disorders: A Narrative Review
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Cryotherapy versus fractional carbon dioxide laser in patchy alopecia areata: a self-controlled comparative study
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
- Retrospective Assessment of Changes in Perceived Health Status during Continuous Use of a Dietary Supplement
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Efficacy of finasteride for treating patients with androgenetic alopecia who are pileous in other areas: A pilot study in Japan
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Efficacy of Acupuncture Therapy in a Patient with Long-Standing Alopecia Areata: A Case Report
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices
- Evaluation of Anxiety and Depression in Patients with Androgenetic Alopecia in Shanghai: A Cross-Sectional Study
- Effects of Nursing Intervention Based on Health Belief Model on Self‐Perceived Burden, Drug Compliance, and Quality of Life of Renal Transplant Recipients
- Quality of life in Romanian patients with schizophrenia based on gender, type of schizophrenia, therapeutic approach, and family history
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Rapid onset of action of minoxidil 5% topical solution in a 4-month German observational study on both patients and physicians
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Assessment of androgenic hormones and other risk factors in Egyptian males with early onset androgenetic alopecia: a case control study
- Assessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss
- SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind
- The Hairdex Quality of Life Instrument—A Translation and Psychometric Validation in Patients with Alopecia Areata
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Innovative Teaching Strategies for Medical Students: Encouraging Reflection on Patient Experiences Through Creative Methods and Meaningful Connections
- The Dermatologist is Out? Assessment of Dermatologists in Ontario Accepting Ontario Health Insurance Plan (OHIP) Referrals for Hair Loss Evaluation
- Adaptive Triboelectric Nanogenerators for Long-Term Self-Treatment: A Review
- Advances in Laser Therapy for Hidradenitis Suppurativa: A Systematic Assessment of Current Evidence
- Differential Diagnosis of Headache and Vertigo: Topical Minoxidil Self-medication Should Be Considered
- Quality of life impairment among patients with hair disorders attending a tertiary care centre in Goa